IBDEI1UL ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32534,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,32535,0)
 ;;=N34.1^^182^1988^96
 ;;^UTILITY(U,$J,358.3,32535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32535,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,32535,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,32535,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,32536,0)
 ;;=N39.0^^182^1988^99
 ;;^UTILITY(U,$J,358.3,32536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32536,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,32536,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,32536,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,32537,0)
 ;;=N31.0^^182^1988^71
 ;;^UTILITY(U,$J,358.3,32537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32537,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,32537,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,32537,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,32538,0)
 ;;=R31.9^^182^1988^50
 ;;^UTILITY(U,$J,358.3,32538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32538,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,32538,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,32538,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,32539,0)
 ;;=R31.0^^182^1988^48
 ;;^UTILITY(U,$J,358.3,32539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32539,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,32539,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,32539,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,32540,0)
 ;;=R31.2^^182^1988^49
 ;;^UTILITY(U,$J,358.3,32540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32540,1,3,0)
 ;;=3^Hematuria,Microscopic
 ;;^UTILITY(U,$J,358.3,32540,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,32540,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,32541,0)
 ;;=R31.1^^182^1988^47
 ;;^UTILITY(U,$J,358.3,32541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32541,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,32541,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,32541,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,32542,0)
 ;;=N40.0^^182^1988^27
 ;;^UTILITY(U,$J,358.3,32542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32542,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,32542,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,32542,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,32543,0)
 ;;=N40.1^^182^1988^26
 ;;^UTILITY(U,$J,358.3,32543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32543,1,3,0)
 ;;=3^Enlarged Prostate w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,32543,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,32543,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,32544,0)
 ;;=N41.0^^182^1988^80
 ;;^UTILITY(U,$J,358.3,32544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32544,1,3,0)
 ;;=3^Prostatitis,Acute
 ;;^UTILITY(U,$J,358.3,32544,1,4,0)
 ;;=4^N41.0
 ;;^UTILITY(U,$J,358.3,32544,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,32545,0)
 ;;=N45.1^^182^1988^28
 ;;^UTILITY(U,$J,358.3,32545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32545,1,3,0)
 ;;=3^Epididymitis
 ;;^UTILITY(U,$J,358.3,32545,1,4,0)
 ;;=4^N45.1
 ;;^UTILITY(U,$J,358.3,32545,2)
 ;;=^41396
 ;;^UTILITY(U,$J,358.3,32546,0)
 ;;=N45.2^^182^1988^73
 ;;^UTILITY(U,$J,358.3,32546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32546,1,3,0)
 ;;=3^Orchitis
 ;;^UTILITY(U,$J,358.3,32546,1,4,0)
 ;;=4^N45.2
 ;;^UTILITY(U,$J,358.3,32546,2)
 ;;=^86174
 ;;^UTILITY(U,$J,358.3,32547,0)
 ;;=N45.3^^182^1988^29
 ;;^UTILITY(U,$J,358.3,32547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32547,1,3,0)
 ;;=3^Epididymo-orchitis
 ;;^UTILITY(U,$J,358.3,32547,1,4,0)
 ;;=4^N45.3
 ;;^UTILITY(U,$J,358.3,32547,2)
 ;;=^5015707
 ;;^UTILITY(U,$J,358.3,32548,0)
 ;;=N47.2^^182^1988^74
 ;;
 ;;$END ROU IBDEI1UL
